All Episodes
|
164
|
Dr. Robert Scoggins

Podcast 164: Insights into Sepsis Management with Dr. Robert Scoggins

Feb 11, 2024

Episode Summary

As health care professionals grapple with the multifaceted demands of patient care, sepsis emerges as a pervasive threat demanding unwavering attention. In this discussion, Dr. Scoggins, a dedicated pulmonary care physician and Chief Medical Officer of Cytovale, shares profound insights into the realm of sepsis management. From the nuances of timely identification to navigating the delicate balance of treatment, Dr. Scoggins offers a compelling narrative shaped by firsthand experiences and a relentless commitment to patient well-being.

Episode Notes

Dr. Robert Scoggins, Chief Medical Officer, Cytovale

Robert Scoggins, MD, PhD is a seasoned pulmonary and critical care physician and the Chief Medical Officer (CMO) at Cytovale. He began his career in science with an undergraduate degree in Molecular Biology from Vanderbilt University and completed a PhD in Microbiology at the University of Virginia as part of a combined MD, and PhD program. Dr. Scoggins completed his residency in Internal Medicine and fellowship in Pulmonary and Critical Care at Vanderbilt University. Over the last 15 years, he has held a variety of clinical and leadership positions within several health systems across the country, including Chief of Staff and ICU Medical Director at Kootenai Health where he served on the frontlines during the height of the COVID-19 pandemic. As CMO at Cytovale, Dr. Scoggins combines his science, clinical, and hospital organizational skills to oversee Cytovale’s development and commercialization of host response technologies to improve care and outcomes of patients with sepsis.

John Marchica, CEO, Darwin Research Group

John Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.

John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.

About Darwin Research Group

Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

CONNECT WITH US:

🌐 Visit us on the web

🌐 Follow Health Care Rounds on LinkedIn

🌐 Follow Darwin Research Group on LinkedIn

📺 Watch Health Care Rounds on YouTube

🎧 Listen on Apple Podcasts

🎧 Listen on Spotify

⚙️ Health Care Rounds is produced by Grippi Media

Recommended Next

Podcast 197: Making Health Care Costs Simple and Transparent w/ Mark Cuban, Co-Founder, Cost Plus Drugs
Podcast 196: Physician Leadership in a New Era of Health Care w/ Dr. Sowmya Viswanathan, Baycare
Podcast 195: Why Primary Care Is Under Strain w/ Dr. Greg Whisman, Chief Medical Officer, CareMore Health
Podcast 194: Why Health Care Reform Keeps Failing w/ Dr. David Shulkin
Podcast 193: The New Model for Specialty Pharmacy w/ Jigar Thakkar, PharmD
Podcast 192: Making Value-Based Care Work at Scale w/ David Carmouche, MD
Podcast 191: Curing Nursing Burnout Through Education w/ Dr. Adele Webb
Podcast 190: The New Rules of Health System Leadership w/ John D’Angelo, MD, FACEP

Recommended Content

Browse Library
INsights
January 14, 2026

Darwin's Our Take: Lilly’s ‘triple G’ candidate exceeds analysts’ expectations

Read More
INsights
January 5, 2026

Darwin's Our Take: FDA approves Novo Nordisk’s Wegovy pill

Read More
INsights
December 22, 2025

Darwin's Our Take: Another 9 drugmakers agree to most-favored-nation pricing on certain products

Read More
Stay Aware. Stay Informed.

Subscribe to Our Take

Sign up for Our Take Newsletter: highly curated, expert weekly strategic insights for health care executives.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.